![Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19 | Circulation Research Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19 | Circulation Research](https://www.ahajournals.org/cms/asset/f1501fa7-0c96-45e0-8151-a5681831aa0b/circresaha.120.317134.fig03.jpg)
Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19 | Circulation Research
![Strategies to prevent ventilator-associated pneumonia, ventilator-associated events, and nonventilator hospital-acquired pneumonia in acute-care hospitals: 2022 Update | Infection Control & Hospital Epidemiology | Cambridge Core Strategies to prevent ventilator-associated pneumonia, ventilator-associated events, and nonventilator hospital-acquired pneumonia in acute-care hospitals: 2022 Update | Infection Control & Hospital Epidemiology | Cambridge Core](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:20230817144558496-0660:S0899823X22000885:S0899823X22000885_tab3.png?pub-status=live)
Strategies to prevent ventilator-associated pneumonia, ventilator-associated events, and nonventilator hospital-acquired pneumonia in acute-care hospitals: 2022 Update | Infection Control & Hospital Epidemiology | Cambridge Core
![Strategies to prevent ventilator-associated pneumonia, ventilator-associated events, and nonventilator hospital-acquired pneumonia in acute-care hospitals: 2022 Update | Infection Control & Hospital Epidemiology | Cambridge Core Strategies to prevent ventilator-associated pneumonia, ventilator-associated events, and nonventilator hospital-acquired pneumonia in acute-care hospitals: 2022 Update | Infection Control & Hospital Epidemiology | Cambridge Core](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:20230817144558496-0660:S0899823X22000885:S0899823X22000885_tab2.png?pub-status=live)
Strategies to prevent ventilator-associated pneumonia, ventilator-associated events, and nonventilator hospital-acquired pneumonia in acute-care hospitals: 2022 Update | Infection Control & Hospital Epidemiology | Cambridge Core
![Applied Sciences | Free Full-Text | Novel Antimicrobials, Drug Delivery Systems and Antivirulence Targets in the Pipeline—From Bench to Bedside Applied Sciences | Free Full-Text | Novel Antimicrobials, Drug Delivery Systems and Antivirulence Targets in the Pipeline—From Bench to Bedside](https://www.mdpi.com/applsci/applsci-12-11615/article_deploy/html/images/applsci-12-11615-g001.png)
Applied Sciences | Free Full-Text | Novel Antimicrobials, Drug Delivery Systems and Antivirulence Targets in the Pipeline—From Bench to Bedside
![Apoptotic cell death in disease—Current understanding of the NCCD 2023 | Cell Death & Differentiation Apoptotic cell death in disease—Current understanding of the NCCD 2023 | Cell Death & Differentiation](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41418-023-01153-w/MediaObjects/41418_2023_1153_Fig2_HTML.png)
Apoptotic cell death in disease—Current understanding of the NCCD 2023 | Cell Death & Differentiation
Elevated Level of Circulating but Not Urine S100A8/A9 Identifies Poor COVID-19 Outcomes | ACS Infectious Diseases
![JCM | Free Full-Text | Outcomes Associated with Respiratory Failure for Patients with Cardiogenic Shock and Acute Myocardial Infarction: A Substudy of the CULPRIT-SHOCK Trial JCM | Free Full-Text | Outcomes Associated with Respiratory Failure for Patients with Cardiogenic Shock and Acute Myocardial Infarction: A Substudy of the CULPRIT-SHOCK Trial](https://www.mdpi.com/jcm/jcm-09-00860/article_deploy/html/images/jcm-09-00860-g001-550.jpg)
JCM | Free Full-Text | Outcomes Associated with Respiratory Failure for Patients with Cardiogenic Shock and Acute Myocardial Infarction: A Substudy of the CULPRIT-SHOCK Trial
![Repurposing of drugs targeting the cytokine storm induced by SARS‐CoV‐2 - Ng - 2023 - British Journal of Pharmacology - Wiley Online Library Repurposing of drugs targeting the cytokine storm induced by SARS‐CoV‐2 - Ng - 2023 - British Journal of Pharmacology - Wiley Online Library](https://bpspubs.onlinelibrary.wiley.com/cms/asset/5ffc2af7-3216-43c7-b0d3-3e9f540f65cf/bph15987-fig-0001-m.jpg)
Repurposing of drugs targeting the cytokine storm induced by SARS‐CoV‐2 - Ng - 2023 - British Journal of Pharmacology - Wiley Online Library
![The signal pathways and treatment of cytokine storm in COVID-19 | Signal Transduction and Targeted Therapy The signal pathways and treatment of cytokine storm in COVID-19 | Signal Transduction and Targeted Therapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41392-021-00679-0/MediaObjects/41392_2021_679_Fig1_HTML.png)